Liver-targeted platinum-based anticancer drug and its synthesis method
A compound and derivative technology, applied in the field of liver-targeted platinum cancer drugs and their synthesis, can solve the problems of destroying the chemical structure of bile acid, affecting the recognition of bile acid by liver tissue, reducing the liver-targeting properties of compounds, etc. High cancer activity, major clinical application prospects, good liver targeting effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0047] (1) Synthetic method of liver targeting platinum anticancer drug of the present invention
[0048] a) Preparation of 3-TsO-1,1-diethyl cyclobutanedicarboxylate (2)
[0049] Under nitrogen protection, take 5.1g (0.024mol) diethyl 3-hydroxy-1,1-cyclobutanedicarboxylate, 9.6g (0.094mol, 4eq.) triethylamine (Et 3 N), 0.58g (0.0047mol, 20%eq.) of 4-dimethylaminopyridine (DMAP) was added to 10mL of dichloromethane, dissolved after stirring, and 9.0g (0.047mol, 2eq.) of p-toluenesulfonyl chloride (TsCl ) and 10 mL of dichloromethane were mixed and added dropwise in an ice bath. After the addition was complete, the mixture was stirred overnight at room temperature, and the reaction was monitored by TLC to complete. Developing agent: petroleum ether: ethyl acetate = 4:1, R f =0.4, column chromatographic separation (petroleum ether: ethyl acetate = 6:1) yielded 8.2 g of the product, with a yield of 94%.
[0050] b) Preparation of diethyl 3-azido-1,1-cyclobutanedicarboxylate (3...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 